Hajihashemi Parisa, Mohammadifard Noushin, Bateni Motahare, Haghighatdoost Fahimeh, Boshtam Maryam, Najafian Jamshid, Sadeghi Masoumeh, Shabani Niloufar, Sarrafzadegan Nizal
Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Am J Prev Cardiol. 2025 Jan 27;21:100936. doi: 10.1016/j.ajpc.2025.100936. eCollection 2025 Mar.
The association of novel anthropometrics and novel atherogenicity indices with mortality remains uncertain.
To compare the association of novel anthropometrics and atherogenicity indices with all-cause, cardiovascular (CVD), and non-CVD mortality in Iranian adults.
Utilizing data from Isfahan Cohort Study, 5432 participants aged older than 35 years were enrolled. Three anthropometrics indices including a body shape index (ABSI), body roundness index (BRI) and abdominal volume index (AVI), and three atherogenicity indices including atherogenic index of plasma (AIP), Castelli risk index (CRI) and the cholesterol index (CI) were calculated. Cox proportional hazards regression models were used to explore the association between indices and mortality.
After a median follow-up of 11.25 years, the ABSI was independently associated with increased risk of all-cause mortality (HR = 1.43, 95 % CI: 1.07, 1.92; P trend = 0.02). A positive, independent association was also observed between CRI-II (HR = 1.49, 95 % CI: 0.99, 2.25; P trend = 0.04) and AIP (HR = 1.81, 95 % CI: 1.92, 2.27; P trend = 0.01) and CVD mortality. For non-CVD mortality, despite a direct link for ABSI (HR = 1.92, 95 % CI: 1.32, 2.80; P trend = 0.001), an inverse association was found for CI (HR = 0.68, 95 % CI: 0.49, 0.95; P trend = 0.007).
Amongst various investigated anthropometric indices, ABSI was directly related to all-cause and non-CVD mortality. However, atherogenicity indices including CRI-II and AIP could predict the incidence risk of CVD mortality among Iranians. Further studies are warranted to confirm these findings.
新型人体测量学指标和新型致动脉粥样硬化指数与死亡率之间的关联仍不明确。
比较新型人体测量学指标和致动脉粥样硬化指数与伊朗成年人全因死亡率、心血管疾病(CVD)死亡率和非心血管疾病死亡率之间的关联。
利用来自伊斯法罕队列研究的数据,纳入了5432名年龄超过35岁的参与者。计算了三个身体测量指数,包括体型指数(ABSI)、身体圆润度指数(BRI)和腹部容积指数(AVI),以及三个致动脉粥样硬化指数,包括血浆致动脉粥样硬化指数(AIP)、卡斯泰利风险指数(CRI)和胆固醇指数(CI)。采用Cox比例风险回归模型探讨这些指数与死亡率之间的关联。
在中位随访11.25年后,ABSI与全因死亡率风险增加独立相关(风险比[HR]=1.43,95%置信区间[CI]:1.07,1.92;P趋势=0.02)。CRI-II(HR=1.49,95%CI:0.99,2.25;P趋势=0.04)和AIP(HR=1.81,95%CI:1.92,2.27;P趋势=0.01)与CVD死亡率之间也观察到正的独立关联。对于非CVD死亡率,尽管ABSI存在直接关联(HR=1.92,95%CI:1.32,2.80;P趋势=0.001),但CI存在负相关(HR=0.68,95%CI:0.49,0.95;P趋势=0.007)。
在各种研究的人体测量学指标中,ABSI与全因死亡率和非CVD死亡率直接相关。然而,包括CRI-II和AIP在内的致动脉粥样硬化指数可以预测伊朗人CVD死亡率的发病风险。需要进一步研究来证实这些发现。